CLENOST Trademark

Trademark Overview

On Tuesday, June 1, 2010, a trademark application was filed for CLENOST with the United States Patent and Trademark Office. The USPTO has given the CLENOST trademark a serial number of 85051739. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Monday, November 9, 2020. This trademark is owned by Glaxo Group Limited. The CLENOST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
clenost

General Information

Serial Number85051739
Word MarkCLENOST
Filing DateTuesday, June 1, 2010
Status710 - CANCELLED - SECTION 8
Status DateMonday, November 9, 2020
Registration Number4508766
Registration DateTuesday, April 8, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 21, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateMonday, November 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, November 9, 2020CANCELLED SEC. 8 (6-YR)
Monday, April 8, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 8, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, January 21, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 21, 2014PUBLISHED FOR OPPOSITION
Wednesday, January 1, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 18, 2013CASE RETURNED TO EXAMINATION
Tuesday, December 17, 2013NOTICE OF ALLOWANCE CANCELLED
Tuesday, December 17, 2013PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, December 10, 2013ASSIGNED TO PETITION STAFF
Tuesday, November 26, 2013TEAS PETITION TO AMEND BASIS RECEIVED
Wednesday, June 26, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2013EXTENSION 5 GRANTED
Friday, June 21, 2013EXTENSION 5 FILED
Friday, June 21, 2013TEAS EXTENSION RECEIVED
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 12, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 11, 2012EXTENSION 4 GRANTED
Friday, December 7, 2012EXTENSION 4 FILED
Friday, December 7, 2012TEAS EXTENSION RECEIVED
Thursday, June 28, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 27, 2012EXTENSION 3 GRANTED
Monday, June 25, 2012EXTENSION 3 FILED
Monday, June 25, 2012TEAS EXTENSION RECEIVED
Thursday, January 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 18, 2012EXTENSION 2 GRANTED
Thursday, December 15, 2011EXTENSION 2 FILED
Wednesday, January 18, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 15, 2011TEAS EXTENSION RECEIVED
Wednesday, December 14, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 17, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 15, 2011EXTENSION 1 GRANTED
Wednesday, June 15, 2011EXTENSION 1 FILED
Wednesday, June 15, 2011TEAS EXTENSION RECEIVED
Tuesday, December 28, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 2, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 2, 2010PUBLISHED FOR OPPOSITION
Friday, September 24, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, September 24, 2010ASSIGNED TO LIE
Wednesday, September 15, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 13, 2010ASSIGNED TO EXAMINER
Friday, June 4, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, June 4, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

clenost pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic